Financials in USD. Standardized financial statements.
A compact view of how Amexdrug Corporation turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $2.90M | $3.40M | $3.92M | $4.82M | $6.37M | $7.72M | $10.51M | $10.43M | $9.30M | $8.85M |
| Revenue Growth? | -14.6% | -13.2% | -18.8% | -24.3% | -17.6% | -26.5% | +0.8% | +12.1% | +5.1% | 0.0% |
| Cost of Revenue? | $1.75M | $2.32M | $2.88M | $3.83M | $4.81M | $6.24M | $8.77M | $8.47M | $7.71M | $7.77M |
| Gross Profit? | $1.15M | $1.08M | $1.03M | $995,158 | $1.55M | $1.48M | $1.74M | $1.96M | $1.60M | $1.08M |
| Gross Margin? | +39.6% | +31.6% | +26.4% | +20.6% | +24.4% | +19.2% | +16.5% | +18.8% | +17.2% | +12.2% |
| Operating Expenses? | $1.01M | $955,301 | $917,861 | $858,710 | $1.24M | $1.20M | $1.49M | $1.75M | $1.45M | $915,008 |
| Operating Income? | $136,786 | $120,117 | $117,128 | $136,450 | $314,720 | $280,070 | $249,120 | $214,620 | $145,630 | $168,430 |
| EBITDA? | $136,786 | $120,117 | $117,130 | $368,957 | $521,015 | $281,010 | $252,857 | $226,806 | $152,385 | $177,383 |
| Income Before Tax | $40,275 | $11,436 | $35,833 | $74,192 | $195,991 | $216,891 | $201,399 | $168,136 | $111,443 | $150,604 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $1.83 | $56,772 | $37,684 | $50,290 |
| Net Income? | $40,275 | $11,436 | $35,833 | $74,192 | $195,991 | $216,891 | $201,399 | $111,364 | $73,759 | $100,314 |
| EPS? | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Diluted EPS? | $0.00 | $0.00 | $0.00 | $0.04 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality